AU2001257613A1 - Compositions comprising carriers and transportable complexes - Google Patents
Compositions comprising carriers and transportable complexesInfo
- Publication number
- AU2001257613A1 AU2001257613A1 AU2001257613A AU5761301A AU2001257613A1 AU 2001257613 A1 AU2001257613 A1 AU 2001257613A1 AU 2001257613 A AU2001257613 A AU 2001257613A AU 5761301 A AU5761301 A AU 5761301A AU 2001257613 A1 AU2001257613 A1 AU 2001257613A1
- Authority
- AU
- Australia
- Prior art keywords
- carriers
- compositions
- transportable
- complexes
- transportable complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19942300P | 2000-04-23 | 2000-04-23 | |
US60/199,423 | 2000-04-23 | ||
PCT/US2001/040567 WO2001082972A2 (en) | 2000-04-23 | 2001-04-19 | Compositions comprising carriers and transportable complexes |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001257613A1 true AU2001257613A1 (en) | 2001-11-12 |
Family
ID=22737432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001257613A Abandoned AU2001257613A1 (en) | 2000-04-23 | 2001-04-19 | Compositions comprising carriers and transportable complexes |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020136732A1 (en) |
AU (1) | AU2001257613A1 (en) |
WO (1) | WO2001082972A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002028408A2 (en) * | 2000-10-02 | 2002-04-11 | Arizeke Pharmaceuticals, Inc. | Compositions and methods for the transport of biologically active agents across cellular barriers |
US7592143B2 (en) * | 2003-04-18 | 2009-09-22 | Cytovia, Inc. | Methods of treating diseases responsive to induction of apoptosis and screening assays |
WO2006073446A2 (en) * | 2004-04-28 | 2006-07-13 | The Trustees Of The University Of Pennsylvania | Peptide-mediated protein transduction into cells the hematopoietic lineage |
US8017152B2 (en) * | 2005-05-27 | 2011-09-13 | Stratosphere Pharma Ab | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
CA2818173C (en) | 2010-11-30 | 2022-05-03 | Genentech, Inc. | Low affinity blood brain barrier receptor antibodies and uses therefor |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
US4675189A (en) * | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
JPS6098823A (en) * | 1983-11-02 | 1985-06-01 | 株式会社東芝 | Power converter |
US4895724A (en) * | 1985-06-07 | 1990-01-23 | Pfizer Inc. | Chitosan compositions for controlled and prolonged release of macromolecules |
EP0238645A1 (en) * | 1985-10-03 | 1987-09-30 | Biotechnology Research Partners, Ltd. | Novel lipoprotein-based drug-delivery systems |
US5084441A (en) * | 1987-03-04 | 1992-01-28 | Shaw Jack M | Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance |
US5354844A (en) * | 1989-03-16 | 1994-10-11 | Boehringer Ingelheim International Gmbh | Protein-polycation conjugates |
US5182258A (en) * | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
US5278142A (en) * | 1989-03-20 | 1994-01-11 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
GB9021671D0 (en) * | 1990-10-05 | 1990-11-21 | Unilever Plc | Delivery of agents |
WO1995003035A1 (en) * | 1993-07-23 | 1995-02-02 | Massachusetts Institute Of Technology | Polymerized liposomes with enhanced stability for oral delivery |
US5744155A (en) * | 1993-08-13 | 1998-04-28 | Friedman; Doron | Bioadhesive emulsion preparations for enhanced drug delivery |
US6086875A (en) * | 1995-01-17 | 2000-07-11 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of immunogens |
US6485726B1 (en) * | 1995-01-17 | 2002-11-26 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
US6030613A (en) * | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
US5958455A (en) * | 1996-02-09 | 1999-09-28 | Quadrant Holdings Cambridge Ltd | Oral solid dosage forms, methods of making same and compositions thereof |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US6072041A (en) * | 1996-06-03 | 2000-06-06 | Case Western Reserve University | Fusion proteins for protein delivery |
US6042833A (en) * | 1996-06-04 | 2000-03-28 | The Regents Of The University Of California | Cellular internalization of pIgR stalk and associated ligands |
DE69729307D1 (en) * | 1996-09-06 | 2004-07-01 | Medarex Inc | CYANIDINE COMPOSITIONS AND THEIR THERAPEUTIC AND DIAGNOSTIC USES |
US5989535A (en) * | 1997-08-15 | 1999-11-23 | Soma Technologies | Polymeric bioadhesive emulsions and suspensions and methods of treatment |
US6022734A (en) * | 1998-03-07 | 2000-02-08 | Wardlaw Partners, L.P. | Disposable apparatus for determining antibiotic sensitivity of bacteria |
-
2001
- 2001-04-19 AU AU2001257613A patent/AU2001257613A1/en not_active Abandoned
- 2001-04-19 US US09/839,746 patent/US20020136732A1/en not_active Abandoned
- 2001-04-19 WO PCT/US2001/040567 patent/WO2001082972A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001082972A2 (en) | 2001-11-08 |
US20020136732A1 (en) | 2002-09-26 |
WO2001082972A3 (en) | 2003-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
AU2001294192A1 (en) | Solid preparations | |
AUPQ419099A0 (en) | Novel compositions and methods | |
AU2001273569A1 (en) | Perfluoropolyethers and processes therefor and therewith | |
AU2001280599A1 (en) | Compounds and methods | |
AU2001253418A1 (en) | Compounds and methods | |
AU4657001A (en) | Displacing arrangement | |
AU2001232841A1 (en) | Bore-resistant digital goods configuration and distribution methods and arrangements | |
AU2002211717A1 (en) | Stresscopins and their uses | |
AU2002220419A1 (en) | Prolamin-based sustained-release compositions and delayed-onset compositions | |
AU2001236716A1 (en) | Antigenic complexes and methods | |
AU2001243394A1 (en) | Compounds and methods | |
AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
AU1152601A (en) | Compositions and their use | |
AU2001271400A1 (en) | Bioelastomer nanomachines and biosensors | |
AU2001257613A1 (en) | Compositions comprising carriers and transportable complexes | |
AU2001278951A1 (en) | Compounds and methods | |
AU2001288102A1 (en) | Solid preparations | |
AU2001240024A1 (en) | Camptothecin complexes | |
AU4432001A (en) | Trityl-type compounds and their use | |
AU2001282521A1 (en) | OCT preparations | |
AU2001272427A1 (en) | Solid preparations | |
AU8252101A (en) | Oct preparations | |
AU2001252062A1 (en) | Steatosis-modulating factors and uses thereof | |
AU5979300A (en) | Angiopoietin-6 and uses thereof |